红细胞大小变异与多种衰老相关结局的关联
RDW最高组功能受限(35.2% vs 16.0%)、衰弱(30.3% vs 11.3%)和≥2次跌倒(19.2% vs 10.3%)比例均显著高于最低组,住院风险亦升高。结论认为RDW与多种衰老相关结局相关,可能作为生物学衰老标志物。
要点
- RDW最高组功能受限和衰弱比例约为最低组的2倍以上。
- RDW最高组≥2次跌倒风险及住院风险均高于最低组。
- RDW与总死亡及死因别死亡相关,或可标志生物学衰老。
核心结论
- 红细胞大小变异增大与多种衰老相关结局相关,可能具有作为生物学衰老标志物的潜在价值。
研究设计与样本
- RDW分为4组(≤13.0%、13.1%-14.0%、14.1%-15.0%、≥15.1%),基线及7.4年后评估功能受限、衰弱、力量、体能和认知。
- 基线后1年记录跌倒,基线后2年获取住院信息,平均随访8.3年评估死亡。
主要发现
- RDW越大者力量越弱、步速越慢、认知功能越差。
- RDW最高组功能受限比例为35.2%,最低组为16.0%(p < .001)。
- RDW最高组衰弱比例为30.3%,最低组为11.3%(p < .001)。
- RDW最高组≥2次跌倒比例为19.2%,最低组为10.3%(p < .001)。
- RDW最高组住院风险高于最低组,比值比(95%置信区间)为1.8(1.3-2.5)。
关键数值与推荐
- RDW分组界值:≤13.0%、13.1%-14.0%、14.1%-15.0%、≥15.1%。
- RDW最高组vs最低组功能受限35.2% vs 16.0%(p < .001)。
- RDW最高组vs最低组衰弱30.3% vs 11.3%(p < .001)。
- RDW最高组vs最低组≥2次跌倒19.2% vs 10.3%(p < .001)。
- RDW最高组vs最低组住院比值比1.8(95%置信区间1.3-2.5)。
临床怎么用
- 对老年男性可关注RDW升高,将其作为功能受限、衰弱、跌倒和住院风险的提示信息。
- RDW升高者可能需要更全面的老年综合评估和随访监测。
- RDW作为生物学衰老标志物的临床价值尚需进一步研究验证。
局限性
- 研究对象仅为社区居住老年男性,结果外推至女性或其他人群需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: We tested whether greater variation in red blood cell size, measured by red cell distribution width (RDW), may predict aging-related degenerative conditions and therefore, serve as a marker of biological aging. METHODS: Three thousand six hundred and thirty-five community-dwelling older men were enrolled in the prospective Osteoporotic Fractures in Men Study. RDW was categorized into 4 groups (≤13.0%, 13.1%-14.0%, 14.1%-15.0%, and ≥15.1%). Functional limitations, frailty, strength, physical performance, and cognitive function were measured at baseline and 7.4 years later. Falls were recorded in the year after baseline; hospitalizations were obtained for 2 years after baseline. Mortality was assessed during a mean of 8.3 years of follow-up. RESULTS: Participants with greater variability in red cell size were weaker, walked more slowly, and had a worse cognitive function. They were more likely to have functional limitations (35.2% in the highest RDW category vs 16.0% in the lowest, p < .001) and frailty (30.3% vs 11.3%, p < .001). Those with greater variability in red cell size were more likely to develop new functional limitations and to become frail. The risk of having 2 or more falls was also greater (highest 19.2% vs lowest 10.3%, p < .001). The risk of hospitalization was higher in those with the highest variability (odds ratio [95% confidence interval], 1.8 [1.3-2.5]) compared with the lowest. Variability in red cell size was related to total and cause-specific mortality. CONCLUSION: Greater variability in red cell size is associated with diverse aging-related outcomes, suggesting that it may have potential value as a marker for biological aging.
引用
- Kim KM, Lui LY, Browner WS, et al. Association Between Variation in Red Cell Size and Multiple Aging-Related Outcomes. J Gerontol A Biol Sci Med Sci. 2021. PMID: 32894755. doi:10.1093/gerona/glaa217
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。